[Advances in the research of anti-CD20 therapeutic monoclonal antibodies]
{{output}}
As targeted drugs to B-cell malignancies, anti-CD20 monoclonal antibodies have been proved to be important in therapeutic antibody field. With three generations in more than ten years' development, the structures of these drugs have been improved, and many new... ...
